Axon Enterprise (NASDAQ:AXON) Price Target Raised to $142.00 at Credit Suisse Group
Axon Enterprise (NASDAQ:AXON) Price Target Raised to $142.00 at Credit Suisse Group
Axon Enterprise (NASDAQ:AXON – Get Rating) had its price target increased by Credit Suisse Group from $134.00 to $142.00 in a research note released on Wednesday morning, The Fly reports. The firm currently has an outperform rating on the biotechnology company's stock.
據The Fly報道，在週三上午發佈的一份研究報告中，瑞士信貸集團將Axon Enterprise(納斯達克：AXON-GET評級)的目標價從134.00美元上調至142.00美元。該公司目前對這家生物技術公司的股票有跑贏大盤的評級。
A number of other research firms have also weighed in on AXON. JMP Securities restated a buy rating and set a $195.00 target price on shares of Axon Enterprise in a research note on Wednesday, June 1st. Northland Securities dropped their price target on shares of Axon Enterprise from $180.00 to $130.00 in a research note on Thursday, May 12th. StockNews.com upgraded shares of Axon Enterprise from a hold rating to a buy rating in a research note on Saturday, June 18th. Robert W. Baird dropped their price target on shares of Axon Enterprise from $145.00 to $125.00 in a research note on Wednesday, May 11th. Finally, Morgan Stanley lowered shares of Axon Enterprise from an overweight rating to an equal weight rating and set a $120.00 price target on the stock. in a research note on Monday, May 23rd. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus price target of $163.25.
其他一些研究公司也參與了Axon的研究。JMP證券在6月1日星期三的一份研究報告中重申了買入評級，併為Axon Enterprise的股票設定了195.00美元的目標價。Northland Securities在5月12日星期四的一份研究報告中將Axon Enterprise的目標股價從180.00美元下調至130.00美元。在6月18日星期六的一份研究報告中，StockNews.com將Axon Enterprise的股票評級從持有評級上調為買入評級。羅伯特·W·貝爾德在5月11日星期三的一份研究報告中將Axon Enterprise的目標股價從145.00美元下調至125.00美元。最後，摩根士丹利將Axon Enterprise的股票評級從增持下調至持平評級，併為該股設定了120.00美元的目標價。在5月23日星期一的一份研究報告中。一名投資分析師對該股的評級為持有，八名分析師對該公司的評級為買入。根據MarketBeat的數據，該股目前的平均評級為適度買入，共識目標價為163.25美元。
Axon Enterprise Trading Down 0.3 %
Axon企業股價下跌0.3%
NASDAQ:AXON traded down $0.36 on Wednesday, reaching $125.71. 3,253 shares of the company's stock were exchanged, compared to its average volume of 272,527. The company has a quick ratio of 2.18, a current ratio of 2.43 and a debt-to-equity ratio of 0.02. The firm has a market capitalization of $8.93 billion, a price-to-earnings ratio of 64.65 and a beta of 0.66. The business has a fifty day moving average of $97.61 and a 200-day moving average of $112.50. Axon Enterprise has a 52-week low of $82.49 and a 52-week high of $209.00.
納斯達克：Axon週三下跌0.36美元，至125.71美元。該公司股票成交量為3253股，而其平均成交量為272527股。該公司的速動比率為2.18，流動比率為2.43，債務權益比為0.02。該公司的市值為89.3億美元，市盈率為64.65倍，貝塔係數為0.66。該業務的50日移動均線切入位在97.61美元，200日移動均線切入位在112.50美元。Axon Enterprise的52周低點為82.49美元，52周高位為209.00美元。
Insider Buying and Selling at Axon Enterprise
Axon Enterprise的內幕買賣
In other news, Director Mark W. Kroll sold 3,159 shares of the firm's stock in a transaction on Wednesday, June 8th. The stock was sold at an average price of $102.82, for a total value of $324,808.38. Following the completion of the transaction, the director now owns 13,691 shares in the company, valued at $1,407,708.62. The sale was disclosed in a document filed with the SEC, which is available at this link. 6.90% of the stock is owned by corporate insiders.
在其他新聞方面，董事馬克·克羅爾在6月8日星期三的一次交易中出售了3159股該公司股票。這隻股票的平均售價為102.82美元，總價值為324,808.38美元。交易完成後，董事現在擁有該公司13,691股，價值1,407,708.62美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，可以通過以下鏈接獲得。6.90%的股份由企業內部人士持有。
Institutional Inflows and Outflows
機構資金流入和流出
A number of hedge funds have recently made changes to their positions in AXON. Capital International Investors increased its position in Axon Enterprise by 605.2% during the 1st quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company's stock worth $366,449,000 after purchasing an additional 2,283,343 shares in the last quarter. BlackRock Inc. increased its position in Axon Enterprise by 6.2% during the 4th quarter. BlackRock Inc. now owns 7,366,629 shares of the biotechnology company's stock worth $1,156,559,000 after purchasing an additional 426,830 shares in the last quarter. William Blair Investment Management LLC increased its position in Axon Enterprise by 22.2% during the 2nd quarter. William Blair Investment Management LLC now owns 2,130,903 shares of the biotechnology company's stock worth $198,536,000 after purchasing an additional 386,861 shares in the last quarter. State Street Corp increased its position in Axon Enterprise by 13.3% during the 1st quarter. State Street Corp now owns 2,220,692 shares of the biotechnology company's stock worth $305,856,000 after purchasing an additional 261,508 shares in the last quarter. Finally, Capital Group International Inc. CA boosted its stake in Axon Enterprise by 263.6% in the 1st quarter. Capital Group International Inc. CA now owns 286,404 shares of the biotechnology company's stock worth $39,446,000 after buying an additional 207,638 shares during the last quarter. Hedge funds and other institutional investors own 72.06% of the company's stock.
一些對衝基金最近改變了他們在Axon的頭寸。第一季度，Capital International Investors將其在Axon Enterprise的持倉增加了605.2%。Capital International Investors現在持有這家生物技術公司2,660,634股股票，價值366,449,000美元，上個季度又購買了2,283,343股。貝萊德股份有限公司在第四季度增持了安盛企業的股份6.2%。貝萊德股份有限公司現在持有這家生物技術公司的7,366,629股股票，價值1,156,559,000美元，該公司在上個季度又購買了426,830股。威廉·布萊爾投資管理公司在第二季度將其在Axon Enterprise的頭寸增加了22.2%。威廉·布萊爾投資管理公司現在持有這家生物技術公司2130,903股股票，價值198,536,000美元，上個季度又購買了386,861股。道富集團在第一季度將其在Axon Enterprise的頭寸增加了13.3%。道富集團目前持有這家生物技術公司2,220,692股股票，價值305,856,000美元，此前該公司在上個季度又購買了261,508股。最後，資本集團國際公司在第一季度將其在Axon Enterprise的持股增加了263.6%。Capital Group International Inc.目前持有286,404股這家生物技術公司的股票，價值39,446,000美元，上個季度又購買了207,638股。對衝基金和其他機構投資者持有該公司72.06%的股份。
About Axon Enterprise
關於Axon Enterprise
(Get Rating)
(獲取評級)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Axon Enterprise，Inc.在美國和國際上以泰瑟品牌開發、製造和銷售導電能源設備(CED)。它通過兩個部分運作，泰瑟槍和軟件和傳感器。該公司還提供硬件和基於雲的軟件解決方案，使執法部門能夠捕獲、安全存儲、管理、共享和分析視頻和其他數字證據。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
- Find and Profitably Trade Stocks at 52-Week Lows
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- 免費獲取StockNews.com關於Axon Enterprise(Axon)的研究報告
- 找到並獲利於52周低點的股票交易
- 迪士尼(NYSE：DIS)的股票剛剛給了投資者一個巨大的信號
- 清潔能源法案通過後，太陽能股大放異彩
- 顛簸時代的3只穩定成長股
- 大型和小型石油和天然氣類股盈利後反彈
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
接受Axon企業日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收Axon Enterprise和相關公司的最新新聞和分析師評級的每日簡明摘要。